Spire Healthcare Group plc (LON:SPI)
London · Delayed Price · Currency is GBP · Price in GBX 157.60
-1.60 (-1.01%)
May 7, 2026, 2:55 PM GMT
Spire Healthcare Group Market Cap
Spire Healthcare Group has a market cap or net worth of 637.75 million as of May 7, 2026. Its market cap has decreased by -12.43% in one year.
Market Cap
637.75M
Enterprise Value
1.92B
Revenue
1.58B
Ranking
n/a
PE Ratio
39.80
Stock Price
157.60
Market Cap Chart
Since July 18, 2014, Spire Healthcare Group's market cap has increased from 211.00 to 637.75M, an increase of 302,251,874.41%. That is a compound annual growth rate of 253.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 634.55M | -5.57% |
| Dec 31, 2025 | 671.96M | -26.12% |
| Dec 31, 2024 | 909.51M | -0.63% |
| Dec 29, 2023 | 915.29M | -0.60% |
| Dec 30, 2022 | 920.82M | -8.12% |
| Dec 31, 2021 | 1.00B | 60.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.72B |
| Smith & Nephew | 9.54B |
| Oxford Nanopore Technologies | 1.10B |
| CVS Group | 798.38M |
| Oxford Biomedica | 779.81M |
| Allergy Therapeutics | 645.92M |